References
- Geczy A F, Alexander K, Bashir H V, Edmonds J P, Upfold L, Sullivan J. HLA-B27, Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol Rev 1983; 70: 23–50
- Terasaki P I, Yu D TY. Editorial: Regarding the ankylosing spondylitis /Klebsiella/ HLA-B27 problem. Arthritis Rheum 1987; 30: 353–4
- Geczy A F, Sullivan J S, McGuigan LE. Response to the editorial by Terasaki and Yu on the ankylosing spondylitis/Klebsiella/HLA-B27 problem. Arthritis Rheum 1987; 30: 714–5
- Archer J R, Stubbs M M, Geczy AF. Factors influencing the cytotoxicity of antibacterial sera for lymphocytes from ankylosing spondylitis patients. Clin Exp Rheumatol 1988; 6: 35–9
- Archer J R, Winrow V R, McLean IL. Viewpoint: The role of HLA-B27 in arthritis. Br J Rheumatol 1988; 27: 306–9
- Parham P, Lomen C E, Lawlor D A, Ways J P, Holmes N, Coppin H L, Salter R D, Wan A M, Ennis PD. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci (USA) 1988; 85: 4005–9
- Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137–42
- Jocelyn PC. Biochemistry of the SH group. The occurrence, chemical properties, metabolism and biological function of thiols and disulphides. Academic Press, London 1972
- Yang S T, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system. The B-cell line panel designed for the Tenth International Histocompatibility Workshop. Immunobiology of HLA. Vol. 1. Histocompatibility Testing 1987, B Dupont. Springer-Verlag, New York 1989; 11–9
- Stierle H E, Brown K A, Perry J D, Holborow EJ. Increased responsiveness of rheumatoid B lymphocytes to stimulation by Epstein-Barr virus. Rheumatol Int 1983; 3: 7–11
- Grumet F C, Fendly B M, Engleman EG. Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis and Reiter's syndrome, and normal controls. Lancet 1981; i: 174–6
- Grumet F C, Fendly B M, Fish L, Foung S, Engleman EG. A monoclonal antibody (B27M2) subdividing HLA-B27. Hum Immunol 1982; 5: 61–72
- Trapani J A, Vaughan H A, Sparrow R L, Tait B DMC, Kenzie I FC. Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3. Hum Immunol 1983; 7: 205–16
- Ellis S A, Taylor C, McMichael AJ. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum Immunol 1982; 5: 49–59
- McMichael A J, Parham P, Rust N, Brodsky F. A monoclonal antibody that recognises an antigenic determinant shared by HLA-A2 and B17. Hum Immunol 1980; 1: 121–9
- Parham P, Bodmer WF. Monoclonal antibody to a human histocompatibility antigen, HLA-A2. Nature 1978; 276: 397–9
- Berger A E, Davis J E, Cresswell P. Monoclonal antibody to HLA-A3. Hybridoma 1982; 1: 87–90
- Brodsky F M, Parham P, Barnstable C J, Crumpton M J, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979; 47: 3–61
- Seager K, Bashir H V, Geczy A F, Edmonds J, De Vere-Tyndall A. Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979; 277: 68–70
- Kennedy L J, Marsh S GE, Bodmer J. Cytotoxic monoclonal antibodies. Immunobiology of HLA. Vol. 1. Histocompatibility Testing 1987, B Dupont. Springer-Verlag, New York 1989; 301–5
- McLean I L, Perrett D, Winrow V R, Archer JR. Status of an unpaired thiol group on the HLA-B27 epitope. Clin Exp Immunol 1989; 77: 417–21
- Townsend A, Ohlen C, Bastin J, Ljunggren H-G, Foster L, Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989; 340: 443–8
- Chen B P, Parham P. Direct binding of influenza peptides to class I HLA molecules. Nature 1989; 337: 743–5